Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee
Group Eleven Drills 25.6m of 9.2% Zn+Pb and 28 g/t Ag and Extends Deeper Cu-Ag Zone with 17.4m of 35 g/t Ag and 0.31% Cu at Ballywire Discovery
